Combined fetal fraction to analyze the Z-score accuracy of noninvasive prenatal testing for fetal trisomies 13, 18, and 21

[1]  Bin Yu,et al.  The Optimal Cutoff Value of Z-scores Enhances the Judgment Accuracy of Noninvasive Prenatal Screening , 2021, Frontiers in Genetics.

[2]  Z. Lina,et al.  Evaluation of the Z‐score accuracy of noninvasive prenatal testing for fetal trisomies 13, 18 and 21 at a single center , 2021, Prenatal diagnosis.

[3]  F. Hirahara,et al.  Retrospective details of false-positive and false-negative results in non-invasive prenatal testing for fetal trisomies 21, 18 and 13. , 2020, European journal of obstetrics, gynecology, and reproductive biology.

[4]  W. Tan,et al.  Prenatal screening in the era of non-invasive prenatal testing: a Nationwide cross-sectional survey of obstetrician knowledge, attitudes and clinical practice , 2020, BMC Pregnancy and Childbirth.

[5]  Quanfei Huang,et al.  Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China , 2020, Human Genomics.

[6]  Guodong Zhao,et al.  Sequencing Shorter cfDNA Fragments Decreases the False Negative Rate of Non-invasive Prenatal Testing , 2020, Frontiers in Genetics.

[7]  Q. Zheng,et al.  Sequencing shorter cfDNA fragments improves the fetal DNA fraction in noninvasive prenatal testing. , 2019, American journal of obstetrics and gynecology.

[8]  Zhengfeng Xu,et al.  An enrichment method to increase cell-free fetal DNA fraction and significantly reduce false negatives and test failures for non-invasive prenatal screening: a feasibility study , 2019, Journal of translational medicine.

[9]  Dong-mei Wang,et al.  The significance of trisomy 7 mosaicism in noninvasive prenatal screening , 2019, Human Genomics.

[10]  Li Wang,et al.  Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 8141 single pregnancies , 2019, Human Genomics.

[11]  K. M. D'Auria,et al.  Strategies to minimize false positives and interpret novel microdeletions based on maternal copy-number variants in 87,000 noninvasive prenatal screens , 2018, BMC Medical Genomics.

[12]  H. Peeters,et al.  Predicting fetoplacental chromosomal mosaicism during non‐invasive prenatal testing , 2018, Prenatal diagnosis.

[13]  C. Chung,et al.  Clinical Experience of Non-Invasive Prenatal Chromosomal Aneuploidy Testing in 190,277 Patient Samples. , 2016, Current molecular medicine.

[14]  A. Cherry,et al.  Noninvasive prenatal screening for aneuploidy: positive predictive values based on cytogenetic findings. , 2015, American journal of obstetrics and gynecology.

[15]  G. Simoni,et al.  Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results , 2014, Genetics in Medicine.

[16]  C. Cantor,et al.  Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma , 2008, Proceedings of the National Academy of Sciences.

[17]  Y. Blumenfeld,et al.  Cell-free Fetal DNA in Maternal Plasma: Progress and Potential , 2008 .

[18]  I. Sargent,et al.  Presence of fetal DNA in maternal plasma and serum , 1997, The Lancet.